Cite
APA Citation
Park, W., Hrycaj, P., Kovalenko, V., Miranda, P., Gutierrez-Ureña, S., Lee, Y., Lim, M., Ahn, C., Kim, H., Yoo, D., & Braun, J. (n.d.). oP0167 A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis. Annals of the rheumatic diseases, 71, 111. http://access.bl.uk/ark:/81055/vdc_100135177739.0x000062